![](https://www.acepnow.com/wp-content/uploads/2023/06/practice-changers-june-2023.jpg)
Dr. Westafer (@Lwestafer) is an attending physician and research fellow at Baystate Medical Center, clinical instructor at the University of Massachusetts Medical School in Worcester, and co-host of FOAMcast.
Explore This Issue
ACEP Now: Vol 42 – No 06 – June 2023References
- Metlay JP, et al. Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019;200(7):e45–67.
- Pastores SM, et al. Corticosteroid guideline task force of SCCM and ESICM. Guidelines for the diagnosis and management of critical illness-related corticosteroid insufficiency (CIRCI) in critically ill patients (Part II): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017. Intensive Care Med. 2018;44(4):474–7.
- Dequin P-F, et al. Hydrocortisone in severe community-acquired pneumonia. N Engl J Med [Internet]. 2023. Accessed May 13, 2023.
- Andre C. Kalil, et al. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis. 2016;63(5):e61–e111.
- Meduri GU, et al. Low-dose methylprednisolone treatment in critically ill patients with severe community-acquired pneumonia. Intensive Care Med. 2022;48(8):1009–23.
Pages: 1 2 3 | Single Page
No Responses to “Two Big Changes in Community Acquired Pneumonia Treatment”